Compare MDXH & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXH | RCMT |
|---|---|---|
| Founded | 2003 | 1971 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 140.8M |
| IPO Year | 2021 | 1997 |
| Metric | MDXH | RCMT |
|---|---|---|
| Price | $2.40 | $18.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 150.3K | 41.3K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.34 |
| Revenue | N/A | ★ $186,737,000.00 |
| Revenue This Year | $30.78 | $16.29 |
| Revenue Next Year | $18.31 | $6.92 |
| P/E Ratio | ★ N/A | $13.88 |
| Revenue Growth | N/A | ★ 5.83 |
| 52 Week Low | $1.36 | $14.88 |
| 52 Week High | $5.33 | $28.19 |
| Indicator | MDXH | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 19.86 | 48.88 |
| Support Level | $2.34 | $17.77 |
| Resistance Level | $3.72 | $19.04 |
| Average True Range (ATR) | 0.19 | 0.93 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 4.15 | 46.72 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.